期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders:Combining with intranasal delivery 被引量:3
1
作者 Yaosheng Li Honghui Wu +3 位作者 Xinchi Jiang yunfei dong Juanjuan Zheng Jianqing Gao 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2022年第8期3215-3232,共18页
The clinical translation of stem cells and their extracellular vesicles(EVs)-based therapy for central nervous system(CNS) diseases is booming. Nevertheless, the insufficient CNS delivery and retention together with t... The clinical translation of stem cells and their extracellular vesicles(EVs)-based therapy for central nervous system(CNS) diseases is booming. Nevertheless, the insufficient CNS delivery and retention together with the invasiveness of current administration routes prevent stem cells or EVs from fully exerting their clinical therapeutic potential. Intranasal(IN) delivery is a possible strategy to solve problems as IN route could circumvent the brain-blood barrier non-invasively and fit repeated dosage regimens. Herein, we gave an overview of studies and clinical trials involved with IN route and discussed the possibility of employing IN delivery to solve problems in stem cells or EVs-based therapy. We reviewed relevant researches that combining stem cells or EVs-based therapy with IN administration and analyzed benefits brought by IN route. Finally, we proposed possible suggestions to facilitate the development of IN delivery of stem cells or EVs. 展开更多
关键词 Stem cells Extracellular vesicles Central nervous system disorders INTRANASAL Clinical translation STROKE Neurodegenerative disease GLIOMA
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部